Try our Advanced Search for more refined results
Moorer v. Stemgenex Medical Group, Inc. et al
Case Number:
3:16-cv-02816
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
February 28, 2022
Bankrupt Stem Cell Biz To Pay $3.65M In Class Settlement
A California federal judge has given final approval to a $3.65 million class action settlement against StemGenex Medical Group Inc., a stem cell therapy provider that filed for Chapter 7 in 2019, for misleadingly marketing and selling treatments to patients suffering from "incurable diseases and a dearth of hope."
-
September 10, 2019
Stem Cell Biz Facing Fraud Claims Declares Bankruptcy
A medical group facing a certified class action for its alleged fraudulent marketing of stem cell treatments has told a California federal court that it has filed for bankruptcy and will liquidate the business.
-
June 25, 2019
Stem Cell Patients Win Cert. In 'Complex And Troubling' Suit
Stem cell therapy patients accusing a provider of wrongfully marketing and selling stem cell treatments nationwide have attained class certification by a whisker, as a California federal judge cautioned of "dangers down the road" in the "complex and troubling case."
-
January 17, 2017
Stem Cell Group Denies Selling Fraudulent Treatments
A stem cell therapy provider accused of wrongfully marketing and selling stem cell treatments to patients nationwide told a California federal judge Monday to scrap the proposed fraud class action, calling it nothing more than a "fishing expedition."